@prefix nalt: <https://lod.nal.usda.gov/nalt/> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix ns0: <https://lod.nal.usda.gov/naltv#> .
@prefix dc: <http://purl.org/dc/terms/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .

nalt:253709
  skos:prefLabel "cefmetazol"@es, "cefmetazole"@en ;
  a <https://lod.nal.usda.gov/naltv#Chemical>, skos:Concept ;
  skos:broader nalt:148709 .

nalt:253707
  skos:prefLabel "cefoxitina"@es, "cefoxitin"@en ;
  a <https://lod.nal.usda.gov/naltv#Chemical>, skos:Concept ;
  skos:broader nalt:148709 .

<https://lod.nal.usda.gov/naltv#Chemical>
  rdfs:label "Chemical"@en ;
  a owl:Class .

nalt:10194
  skos:prefLabel "cefalosporinas"@es, "cephalosporins"@en ;
  a <https://lod.nal.usda.gov/naltv#Chemical>, skos:Concept ;
  skos:narrower nalt:148709 .

nalt:253708
  skos:prefLabel "cefotetan"@es, "cefotetan"@en ;
  a <https://lod.nal.usda.gov/naltv#Chemical>, skos:Concept ;
  skos:broader nalt:148709 .

<https://lod.nal.usda.gov/nalt>
  rdfs:label "NALT Full"@en ;
  a skos:ConceptScheme .

nalt:148709
  skos:narrower nalt:253709, nalt:253708, nalt:253707 ;
  ns0:marc001 "59542" ;
  skos:hiddenLabel "cephamycin"@en, "cephamycin antibiotics"@en, "cephamycin antibiotic"@en ;
  dc:created "2011-10-04"^^xsd:date ;
  skos:inScheme <https://lod.nal.usda.gov/nalt> ;
  skos:definition nalt:148709_def ;
  a ns0:Chemical, skos:Concept ;
  dc:modified "2015-05-26"^^xsd:date ;
  skos:prefLabel "cephamycins"@en, "cefamicinas"@es ;
  skos:broader nalt:10194 .

nalt:148709_def
  rdf:value "De origen natural. Familia de las cefalosporinas de tipo beta-lactámicos, con un grupo de 7-metoxi y el cual posee una marcada resistencia a la acción de las beta-lactamasas de organismos gram-positivos y gram-negativos."@es, "Naturally occurring family of beta-lactam cephalosporin-type antibiotics having a 7-methoxy group and possessing marked resistance to the action of beta-lactamases from gram-positive and gram-negative organisms."@en ;
  dc:source "Medical Subject Headings 2011" ;
  a ns0:Definition .